Keyphrases
Glioblastoma
100%
Indoleamine 2,3-dioxygenase 1 (IDO1)
100%
Pathway Control
100%
Chemoradiation Therapy
100%
Tumor
23%
Complement Deposition
23%
Glioblastoma multiforme
15%
Vascular Activation
15%
Chemoradiation
15%
Solid Tumors
7%
Tumor Growth
7%
Allogeneic
7%
Evade
7%
Pharmacological Inhibitors
7%
Leukocytes
7%
Adaptive Immune Response
7%
Immune Response
7%
Synergistic Effect
7%
Chemotherapy
7%
Vascular Endothelium
7%
T-cell Mediated
7%
Syngeneic
7%
Tumor Cells
7%
Radiation Effects
7%
Pharmacologic
7%
Downstream Effectors
7%
Beneficial Effects
7%
Effector Mechanisms
7%
Radiation Therapy
7%
Tumor Microenvironment
7%
Right Frontal Lobe
7%
Complement C3
7%
Vascular Cell Adhesion molecule-1 (VCAM-1)
7%
Maternal Treatment
7%
Chemotherapy Treatment
7%
Glioma Model
7%
Syngeneic Mice
7%
Immune-suppressive
7%
Medicine and Dentistry
Glioblastoma
100%
Indoleamine 2,3 Dioxygenase
100%
Chemoradiation Therapy
100%
Neoplasm
53%
Immunity
23%
Complement Deposition
23%
Upregulation
15%
Chemoradiotherapy
15%
Tumor Progression
7%
Solid Malignant Neoplasm
7%
Leukocyte
7%
T Cell
7%
Tumor Cell
7%
Complement Component C3
7%
Tumor Microenvironment
7%
T-Cell Response
7%
Frontal Lobe
7%
Adaptive Immunity
7%
Vascular Cell Adhesion Molecule 1
7%
Vascular Endothelium
7%
Radiation Therapy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Chemoradiation Therapy
100%
Indoleamine 2,3 Dioxygenase
100%
Neoplasm
61%
Chemotherapy
15%
Solid Malignant Neoplasm
7%
Tumor Growth
7%
Tumor Microenvironment
7%
Complement Component C3
7%
Vascular Cell Adhesion Molecule 1
7%
Immunology and Microbiology
Indoleamine 2,3-dioxygenase
100%
Immunity
23%
Complement Deposition
23%
T Cell
15%
Upregulation
15%
Syngenic
15%
Leukocyte
7%
Adaptive Immune System
7%
Vascular Endothelium
7%
Tumor Cell
7%
Complement Component 3
7%
VCAM-1
7%
Frontal Cortex
7%
Biochemistry, Genetics and Molecular Biology
Indoleamine 2,3-dioxygenase
100%
Complement Deposition
23%